Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.098

€0.098

5.380%
0.005
5.380%
-
 
25.04.24 / Frankfurt WKN: A0M8VQ / Name: E-Therapeutics / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

E-Therapeutics Plc Stock

E-Therapeutics Plc dominated the market today, gaining €0.005 (5.380%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for E-Therapeutics Plc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of E-Therapeutics Plc in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of E-Therapeutics Plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
E-Therapeutics Plc 5.380% - - - - - -
Byotrol plc - 0.000% 0.000% -95.238% -85.714% -99.342% -
Proteome Sciences - 0.000% 0.000% 17.647% 6.667% -32.203% 166.667%
Oxford BioMedica PLC 0.830% 9.009% 14.151% -47.845% -0.820% -80.484% -69.367%

News

Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery